Skip to content

Anterior vs Posterior Surgery for Lumbar Isthmic Spondylolisthesis

Anterior vs Posterior Surgery for Lumbar Isthmic Spondylolisthesis: Multicenter Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05701046
Enrollment
489
Registered
2023-01-27
Start date
2023-01-05
Completion date
2038-02-15
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Isthmic Spondylolisthesis

Brief summary

Currently there is no consensus on the best surgical treatment of patients with symptomatic isthmic spondylolisthesis (IS). Clinical equipoise exists amongst experienced clinicians on the various surgical techniques available. This study will involve multiple phases to answer specific research questions comparing anterior and posterior interbody fusion in patients with lumbar isthmic spondylolisthesis. The primary end point will be 1-year proportions of patients reaching minimal clinically important difference (MCID) in terms of leg pain measured by NRS leg. The secondary endpoints will be predetermined moderate to severe AEs, reoperations for nonunion, symptomatic adjacent segment disease, radiological alignment correction and correlation with HRQOL as well as economic analysis at 1, 2, 5 and 10 years.

Interventions

PROCEDUREInterbody fusion surgery

Interbody fusion surgery

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female aged 18 years or older (or who have reached the age of majority in the participating province) * Require surgical treatment for a diagnosis of single-level lumbar isthmic spondylolisthesis, any grade, in the lumbar and lumbosacral spine. * Are able to communicate in English or French * Anterior interbody fusion group will be defined as having had an anterior or oblique approach with a synthetic cage insertion, interbody bone graft without cage or plate-screw construct with or without posterior rod-screw construct * Posterior interbody fusion group will have only posterior approach procedure.

Exclusion criteria

* Previous spinal surgery * Specific pathology at level above and below: * Degenerative anterolisthesis * Pars defect above or below index level

Design outcomes

Primary

MeasureTime frameDescription
Proportions of patients reaching MCID for NRS leg at 1 yearat 1 year follow-upProportions of patients reaching MCID for NRS leg (\>=3)

Secondary

MeasureTime frameDescription
Change in Patient's reported outcome (PRO) : Patient Health Questionnaire Depression Scale (PHQ-8)1 year- 2 year -5 year -10 year follow-up data
Proportion of patients with any predefined adverse events3 month follow-up data
Reoperation due to nonunion at index level or adjacent segment disease1 year- 2 year -5 year -10 year follow-up data
Change in radiological parameters1 year- 2 year -5 year -10 year follow-up dataLevel, Labelle classification, Degree of translation, SVA, Lumbar lordosis, segmental lordosis, sacral and spinopelvic parameters,
Change in Patient's reported outcome (PRO) : 12 item short form survey (SF12)1 year- 2 year -5 year -10 year follow-up data
Change in Patient's reported outcome (PRO) : Numeric pain rating scale for back pain1 year- 2 year -5 year -10 year follow-up data
Change in Patient's reported outcome (PRO) : Oswestry disability index1 year- 2 year -5 year -10 year follow-up data
Change in Patient's reported outcome (PRO) : EuroQoL 5 dimension (EQ5D)1 year- 2 year -5 year -10 year follow-up data
Correlation between improvement in radiological parameters and patient reported outcomes1 year- 2 year -5 year -10 year follow-up data

Countries

Canada

Contacts

Primary ContactCharlotte Dandurand
charlotte.dandurand@vch.ca(604) 875-5859

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026